Dare Bioscience Inc (DARE)
3.28
+0.06
(+1.86%)
USD |
NASDAQ |
Sep 27, 16:00
3.28
0.00 (0.00%)
After-Hours: 18:30
Dare Bioscience Cash from Investing (Quarterly): -0.2852M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.2852M |
| March 31, 2024 | -0.0073M |
| December 31, 2023 | -0.6073M |
| September 30, 2023 | -0.0221M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0027M |
| September 30, 2022 | -0.055M |
| June 30, 2022 | -0.0008M |
| March 31, 2022 | -0.0046M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0145M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0024M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.0152M |
| March 31, 2020 | |
| December 31, 2019 | 6.144M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | -0.0586M |
| June 30, 2018 | -0.4602M |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 9.918M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.355M |
| June 30, 2016 | -0.113M |
| March 31, 2016 | -0.242M |
| December 31, 2015 | -0.113M |
| September 30, 2015 | -0.034M |
| June 30, 2015 | -0.308M |
| March 31, 2015 | -0.029M |
| December 31, 2014 | -0.109M |
| September 30, 2014 | -0.078M |
| June 30, 2014 | 0.006M |
| March 31, 2014 | -0.004M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.002M |
| June 30, 2013 | -0.003M |
| March 31, 2013 | -0.002M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.6073M
Minimum
Dec 2023
6.144M
Maximum
Dec 2019
0.2698M
Average
-0.0024M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 12.90M |
| Cash from Financing (Quarterly) | 0.1154M |
| Free Cash Flow | -10.98M |
| Free Cash Flow Per Share (Quarterly) | 17.87 |
| Free Cash Flow to Equity (Quarterly) | 12.62M |
| Free Cash Flow Yield | -55.89% |